Faculty

Dr. Aminu Bello

Assistant Professor

Department of Medicine

Division of Nephrology

About Me

Dr Bello is an Assistant Professor of Medicine at the University of Alberta and Attending Physician at the University of Alberta Hospital. He qualified as a medical doctor in Nigeria at Usmanu Danfodiyo University, Sokoto, and underwent specialist clinical training in internal medicine, nephrology, and epidemiology in Ibadan, Nigeria; Sheffield, UK; and Edmonton. He holds multiple research grants from major provincial and national research organizations including the Canadian Institutes of Health Research (CIHR). He reviews regularly for the major general medical and nephrology journals including The Lancet and Kidney International. He has more than 80 peer-reviewed scientific publications and is keenly interested in global health initiatives to improve nephrology practice and education in emerging nations.

Training and education
•    Fellowship of the Royal College of Physicians (FRCP), 2013
•    Specialist Registration (Renal), General Medical Council (UK), 2012
•    Postdoctoral Research Fellowship (supervised by Dr Marcello Tonelli) in Nephrology, University of Alberta, Edmonton, Canada, 2011-2012
•    Clinical Fellowship in Nephrology & Transplantation, University of Alberta, 2010-2011
•    Clinical Fellow in Nephrology/Honorary Lecturer, Sheffield Teaching Hospital NHS Trust, 2004-2009
•    PhD in Nephrology/Epidemiology (supervised by Professor Meguid El Nahas), University of Sheffield, 2003-2007
•    MMedSci (with Distinction) in Nephrology, University of Sheffield, 2002-2003
•    Residency Training in General Internal Medicine, University College Hospital, Ibadan, Nigeria, 2000-2002
•    MBBS (MD), Usmanu Danfodiyo, Nigeria, 1992-1998

Teaching

Dr Bello supervises summer and graduate (MSci and PhD) students, residents, and fellows in research projects. He serves as a course tutor for a renal epidemiology course for nephrology fellows at the University of Alberta. He trains residents and medical students on in-patient service.

He regularly speaks at national and international conferences:

Recent Scholarly Presentations

International
2017 Invited speaker: Announcing results from the first-ever Global Kidney Health Atlas. World Congress of Nephrology (WCN), Apr 21-25, Mexico City. 
2017 Invited speaker: Kidney care in low and middle income countries. 11th Conference on Kidney Disease in Disadvantaged Populations, Apr 25-26, Santiago de Queretaro, Mexico. 
2016 Invited speaker: Patient-oriented research in nephrology: challenge and opportunities for developing nations. Annual Scientific Conference and General Meeting of the Nigerian Association of Nephrology, Feb 14-18, Sokoto, Nigeria.
2016 Invited speaker: Progressive CKD: Current status of care and implications for renal replacement therapy modality option in resource poor settings. Annual Scientific Conference and General Meeting of the Nigerian Association of Nephrology, Feb 14-18, Sokoto, Nigeria.

National 
2017 Invited speaker: Nephrology advice consult & e-referral for primary care. Alberta Kidney Days 2017: Excellence in Kidney Care – The Power of Partnerships, March 10-11, Calgary. 
2016 Invited speaker: Challenges and opportunities in delivering optimal kidney care to remote dwelling and Northern Canadians with CKD. Canadian Society of Nephrology Administrators (CANA) at CSN, May 11, Halifax.

Research

Dr. Bello is a clinician-scientist with research interests in improving outcomes in patients with chronic kidney disease (CKD). Central themes are innovative care delivery pathways, rural/remote health, global kidney health initiatives, novel risk markers for adverse outcomes in the CKD population, and preventing disease progression and reducing risk of complications. He studies and designs programs to optimize delivery of care to disadvantaged populations (remote, rural, and/or Aboriginal) with CKD.

Research Projects:
Global kidney health and CKD epidemiology:Landmark reviews by Dr Bello have drawn attention to CKD as an important public health issue. At the invitation of the International Society of Nephrology (ISN), he co-chaired the development of the Global Kidney Health Atlas (GKHA) Project, which assessed for the first time the current capacity for kidney care across all world regions.

Representative contributions:

  1. Bello AK, Levin A, Tonelli M, Okpechi IG, Feehally J, Harris D, Jindal K, Salako BL, Rateb A, Osman MA, Qarni B, Saad S, Lunney M, Wiebe N, Ye F, Johnson DW. Assessment of global kidney health care status. JAMA, 2017; 317:1864-1881.
  2. Thomas B, Matsushita K, Abate HK, Al-Aly Z, Arnlov J, Asayama K, Atkins R, Badawi A, Ballew SH, Banerjee A, Barregard LM Barrett-Connor, E, Basu S, Bello AK, Bensenor I, Bergstrom J, Bikbov B, et al. Global Cardiovascular and Renal Outcomes of Reduced GFR. J Am Soc Nephrol 2017, Apr 13 (epub ahead of print).
  3. Bruck K, Stel VS, Gambaro G, Hallan S, Volzke H, Arnlov J, Kastarinen M, Guessous I, Vinhas J, Stengel B, Brenner H, Chudek J, Romundstad S, Tomson C, Gonzalez AO, Bello AK, Ferrieres J, Palmieri L, Browne G, Capuano V, Van Biesen W, Zoccali C, Gansevoort R, Navis G, Rothenbacher D, Ferraro PM, Nitsch D, Wanner C, Jager KJ. CKD Prevalence Varies across the European General Population. J Am Soc Nephrol 2016; 27: 2135-47
  4. Bello AK, Levin A, Manns BJ, Feehally J, Drueke T, Faruque L, Hemmelgarn BR, Kernahan C, Mann J, Klarenbach S, Remuzzi G, Tonelli M. Effective CKD care in European countries: challenges and opportunities for health policy. Am J Kidney Dis 2015; 65: 15-25.
  5. Bello AK, Kawar B, M El Kossi, El Nahas AM. Epidemiology & Pathophysiology of Chronic Kidney Disease. In Comprehensive Clinical Nephrology. Editors, John Fehally, Floege and Johnson.4th Edition. Publisher: Elsevier, 2011.
  6. Bello AK, Tonelli M, Jagger K. Renal Disease- Epidemiology. In Oxford Textbook of Clinical Nephrology. Editors, Davison, Cameron and Winearls.4th Edition. Publisher: Oxford University Press, 2015.
  7. Bello AK, Nwankwo E, El Nahas AM. Prevention of Chronic Kidney Disease: A Global Challenge. Kidney International, 2005: S98: S11-7.

    Regional and social inequalities in kidney health: Dr Bello explores the mechanisms by which, as is well established, socio-economic status and geography affect health. His team in the UK used a large CKD cohort database and sophisticated geographical information systems (GIS) to show that subjects living in socio-economically deprived areas presented with more advanced CKD. Since coming to Alberta, he has shown that remotely located patients with CKD are less likely to receive recommended quality care and more likely to experience adverse health outcomes. He built a national collaborative team of experts that investigates how care varies in relation to patient and provider characteristics and by region across Canada.

    Representative contributions:
  8. Bello AK, A.A. Abdel Rahman, Rigby J, Peters J, El Nahas AM. Socio-economic status and Chronic Kidney Disease at Presentation to a Renal Service in the UK. Clinical Journal of the American Society of Nephrology; 2008; 3:1316-1323.
  9. Bello AK, Peters J, Wight J, de Zeeuw D,  El Nahas AM. A Population-based Screening for Microalbuminuria among Relatives of CKD Patients: The Kidney Evaluation and Awareness Program in Sheffield (KEAPS). American Journal of Kidney Diseases, 2008; 52:434-443.
  10. Bello AK, Hemmelgarn B, Lloyd A, James MT, Manns BJ, Klarenbach S, Tonelli M. Associations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomes . Clin J Am Soc Nephrol 2011; 6(6): 1418-26. 
  11. Rucker D, Hemmelgarn BR, Lin M, Manns BJ, Klarenbach SW, Ayyalasomayajula B, James MT, Bello AK, Gordon D, Jindal KK, Tonelli M. Quality of care and mortality are worse in chronic kidney disease patients living in remote areas. Kidney Int 2011; 79(2): 210-7.
  12. Bello AK, Hemmelgarn BR, Lloyd A,   Klarenbach SW,  Manns BJ, Tonelli  M. Multiple Versus Single and Other Estimates of Baseline Proteinuria Status as Predictors of Adverse Outcomes in the General Population, American Journal of Kidney Diseases, 2012;59:364-71.
  13. Bello AK, Hemmelgarn BR, Lloyd A, Klarenbach SW, James MT,  Manns BJ, Tonelli  M. Impact of remote location on quality care delivery and relationships to  adverse outcomes in patients with diabetes and chronic kidney disease. Nephrol Dial Transplant, 2012; 27:3849-3855.
  14. Bello AK, Hemmelgarn BR, Lloyd A,   Klarenbach SW, James MT,  Manns BJ, Tonelli  M. A Population-based study on care and clinical outcomes in remote-dwellers with heavy proteinuria. Kidney International Suppl 3, 201 3; 254-258. 
  15. Ayyalasomayajula B, Wiebe N, Hemmelgarn BR, Bello AK, Manns B, Klarenbach S, Tonelli M.  A novel technique to optimize facility locations of new nephrology services for remote areas. Clin J Am Soc Nephrol 2011; 6(9): 2157-64.

    Delivery of CKD care with a specific focus on remote areas: Dr Bello therefore conducts policy-relevant research on interventions to improve care delivery and outcomes among remote/rural dwellers with CKD in Alberta. He has helped develop innovations such as an e-Consult system linking family physicians to kidney specialists, and a CKD surveillance system in primary care.

    Representative contributions:
  16. Akbari A, Clase CM, Acott P, Battistella M, Bello A, Feltmate P, Grill A, Karsanji M, Komenda P, Madore F, Manns BJ, Mahdavi S, Mustafa RA, Smyth A, Welcher ES. Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management. Am J Kidney Dis 2015; 65(2): 177-205.
  17. Bello AK, Anita E. Molzahn, Louis P Girard, Mohamed A. Osman, Ikechi G Okpechi, Jodi Glassford, Stephanie Thompson, Erin Keely, Clare Liddy, Braden Manns, Kailash Jinda, Scott Klarenbach, Brenda Hemmelgarn, Marcello Tonelli. . Patient and provider perspectives on the design and implementation of an electronic consultation system for kidney care delivery in Canada: A focus group study. BMJ Open, 2017 (In press)
  18. Bello AK, Qarni B, Samimi A, Okel J, Chatterley T, Okpechi IG, Vandermeer B, Braam B. Effectiveness of multifaceted care approach on adverse clinical outcomes in non-diabetic CKD: A systematic review and meta-analysis. Kidney International Reports, 2017 (In Press)
  19. Osman M, Okel J, Okpechi IG, Jindal, K. Bello AK. Potential applications of telenephrology to enhance global kidney care. BMJ Global Health, 2017 (In Press)
  20. Bello AK, Ronksley P, Tangri N, Grill A, Singer A, Mangin D, Drummond N. Improving CKD management in primary care using the Canadian Primary Care Sentinel Surveillance Network: A study protocol of a retrospective observational study. BMJ Open, 2017 (In press)

    Collaboration: Dr Bello seeks to improve kidney care in collaboration with 
    •    the Alberta Kidney Disease Network (AKDN)
    •    the Kidney Health Strategic Clinical Network (Kidney Health SCN) 
    •    the Canadian Primary Care Sentinel Surveillance Network (CPCSSN)
    •    Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD)
    •    the Global Burden of Disease (GBD) collaboration.

Research Keywords

Cancer, Determinants of Health, Epidemiology, Quality of Care, Rural or Remote Residence Location, Screening